CRBNpathway
1 gene is key to drug resistance in multiple myeloma
1 gene is key to drug resistance in multiple myeloma Researchers at the National University of Singapore have identified a key gene, ADAR1, that contributes to drug resistance in multiple myeloma patients. The study found that ADAR1 inhibits lenalidomide’s activity by editing double-stranded RNA, suppressing the immune response and reducing the effectiveness of the drug. […]
🏥 Health